Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Borato-1, 2-diaminocyclohexane platinum (II), a novel anti-tumor drug
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Borato-1, 2-diaminocyclohexane platinum (II), a novel anti-tumor drug'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Anticancer Drugs
100%
Platinum(II)
100%
1,2-Diaminocyclohexane
100%
Cisplatin
71%
L1210
42%
Optimal Dose
28%
Breast Cancer Cells
14%
Leukemia
14%
Tumor Cells
14%
Leukemia Cells
14%
MCF-7
14%
DNA Synthesis
14%
Cisplatin-induced
14%
Human Prostate Cancer Cells
14%
Lethal Dose 50 (LD50)
14%
Murine Leukemia
14%
Tumor Model
14%
Murine Cells
14%
Platinum Derivatives
14%
3H-thymidine Incorporation
14%
Tumor Mouse Model
14%
A549 Lung Carcinoma
14%
Lung Carcinoma Cells
14%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
1,2 Diaminocyclohexane
100%
Platinum
100%
Cisplatin
85%
Mouse Model
14%
Prostate Cancer
14%
Leukemia
14%
Breast Cancer
14%
Thymidine
14%
Murine Leukemia
14%
Tumor Model
14%
Lung Carcinoma
14%
Platinum Derivative
14%
B6D2F1 Mouse
14%